Cambridge Investment Research Advisors’s Nuveen New York Tax-Free Income Portfolio NXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,525
Closed -$550K 4030
2025
Q4
$550K Sell
45,525
-446
-1% -$5.39K ﹤0.01% 2629
2025
Q3
$553K Buy
+45,971
New +$538K ﹤0.01% 2578
2025
Q2
Sell
-18,971
Closed -$224K 3725
2025
Q1
$224K Sell
18,971
-3,941
-17% -$46.1K ﹤0.01% 3106
2024
Q4
$260K Sell
22,912
-27,950
-55% -$332K ﹤0.01% 2968
2024
Q3
$619K Buy
50,862
+6,039
+13% +$71.5K ﹤0.01% 2239
2024
Q2
$524K Sell
44,823
-175
-0.4% -$2.04K ﹤0.01% 2261
2024
Q1
$524K Buy
44,998
+217
+0.5% +$2.55K ﹤0.01% 2238
2023
Q4
$526K Buy
44,781
+26,141
+140% +$296K ﹤0.01% 2140
2023
Q3
$215K Buy
18,640
+5,014
+37% +$59.8K ﹤0.01% 2758
2023
Q2
$162K Buy
+13,626
New +$163K ﹤0.01% 2929

Cambridge Investment Research Advisors's NXN Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Nuveen New York Tax-Free Income Portfolio (NXN) in Q1 2026, closing a stake of 45,525 shares — an estimated $550K sold.

Cambridge Investment Research Advisors first reported a position in NXN in Q2 2023 and held it in 10 quarters. The position peaked at $619K in Q3 2024. 0 funds tracked by Wall St. Rank hold NXN as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Nuveen New York Tax-Free Income Portfolio position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 45,525 Nuveen New York Tax-Free Income Portfolio shares in Q1 2026, an estimated $550K.
  • Cambridge Investment Research Advisors first reported a position in Nuveen New York Tax-Free Income Portfolio in Q2 2023 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's Nuveen New York Tax-Free Income Portfolio position peaked at $619K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Nuveen New York Tax-Free Income Portfolio as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.